Lanconone®
Dietary Supplement2 capsules
NCT Number: NCT03658369
The current study has been designed to primarily assess the effect of Lanconone® in comparison to placebo on pain in weight bearing joints.
Looking for future studies?
Notify Me40 year–65 year
All sexes
Interventional
Not applicable
Ayush Nursing Home, Mumbai, Maharashtra, India
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 capsules
2 Capsules
Time frame: 56 days
Change in pain score.The score ranges from 0-5, wherein 0 indicates no pain and 5 indicates extreme pain.
Vedic Lifesciences Pvt. Ltd.
Industry
To Assess the Lanconone® (E-OA-07) Efficacy in Weight-bearing Joint Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07258693
Osteo Arthritis Knee
Las Palmas de Gran Canaria, Spain
View Trial DetailsNCT06257537
Arthritis, Joint Diseases
Stamford, Connecticut, United States
View Trial DetailsNCT06965946
Arthritis, Joint Diseases
Peshawar, Khyber Pakhtunkhwa, Pakistan
View Trial DetailsNCT06084988
Osteo Arthritis Knee
Abu Dhabi, United Arab Emirates
View Trial Details